Sonoma Pharmaceuticals (SNOA) Current Deferred Revenue (2011 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Current Deferred Revenue of $314000.0 in Q4 2025, down 58.13% quarter-over-quarter from $750000.0 in Q3 2025, and up 3.97% on a YoY basis from $302000.0 in Q4 2024.
Sonoma Pharmaceuticals (SNOA) Current Deferred Revenue (2011 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Current Deferred Revenue history runs 15 years deep, the most recent figure standing at $314000.0 for Q4 2025.
- In Q4 2025, Current Deferred Revenue rose 3.97% year-over-year to $314000.0; the TTM figure through Dec 2025 stood at $314000.0 (up 3.97% YoY), while the FY2025 annual figure was $641000.0, up 321.71% from the prior year.
- Current Deferred Revenue was $314000.0 for Q4 2025 at Sonoma Pharmaceuticals, down from $750000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1.2 million in Q1 2022 to a low of $75000.0 in Q4 2023.
- Historically, Current Deferred Revenue has averaged $313600.0 across 5 years, with a median of $192000.0 in 2021.
- The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue jumped 358.05% in 2022, then slumped 83.73% in 2023.
- A 5-year view of Current Deferred Revenue shows it stood at $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022, then decreased by 25.0% to $75000.0 in 2023, then surged by 302.67% to $302000.0 in 2024, then advanced by 3.97% to $314000.0 in 2025.
- The last three Current Deferred Revenue figures came in at $314000.0 (Q4 2025), $750000.0 (Q3 2025), and $731000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 314,000.00 |
| Sep 30, 2025 | 750,000.00 |
| Jun 30, 2025 | 731,000.00 |
| Mar 31, 2025 | 641,000.00 |
| Dec 31, 2024 | 302,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Jun 30, 2024 | 413,000.00 |
| Mar 31, 2024 | 152,000.00 |
| Dec 31, 2023 | 75,000.00 |
| Sep 30, 2023 | 101,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 199,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 185,000.00 |
| Mar 31, 2021 | 267,000.00 |